Facchin A, Filipe J, Mauri I, Tagliasacchi F, Grilli G, Vitiello T
Antibiotics (Basel). 2025; 14(1.
PMID: 39858317
PMC: 11760867.
DOI: 10.3390/antibiotics14010031.
Tsitsos A, Damianos A, Kiskinis K, Tsiouris V, Tirodimos I, Soultos N
Foods. 2025; 14(2).
PMID: 39856891
PMC: 11764975.
DOI: 10.3390/foods14020224.
Ayinla A, Mateus A
Front Antibiot. 2025; 2():1140750.
PMID: 39816659
PMC: 11732038.
DOI: 10.3389/frabi.2023.1140750.
Xu T, Shi Y, Cao X, Xiong L
Microbiol Spectr. 2024; 13(1):e0217024.
PMID: 39641574
PMC: 11705954.
DOI: 10.1128/spectrum.02170-24.
Lei Z, Li Z, Zhang Y, Zeng L, Wu Y, Zhang F
Ann Clin Microbiol Antimicrob. 2024; 23(1):99.
PMID: 39516891
PMC: 11549737.
DOI: 10.1186/s12941-024-00743-x.
Prevalence, Characterization, and Epidemiological Relationships between ESBL and Carbapenemase-Producing , and spp. Isolated from Humans and the Kitchen Environment of Two Greek Hospitals.
Tsitsos A, Damianos A, Boutel M, Gousia P, Soultos N, Papa A
Antibiotics (Basel). 2024; 13(10).
PMID: 39452201
PMC: 11504295.
DOI: 10.3390/antibiotics13100934.
AMR and Sustainable Development Goals: at a crossroads.
Aslam B, Asghar R, Muzammil S, Shafique M, Siddique A, Khurshid M
Global Health. 2024; 20(1):73.
PMID: 39415207
PMC: 11484313.
DOI: 10.1186/s12992-024-01046-8.
Rapid Reversal of Carbapenemase-Producing Epidemiology from - to -harbouring Isolates in a Greek Tertiary Care Hospital.
Protonotariou E, Meletis G, Vlachodimou N, Malousi A, Tychala A, Katsanou C
Antibiotics (Basel). 2024; 13(8).
PMID: 39200062
PMC: 11350812.
DOI: 10.3390/antibiotics13080762.
Plasmid-Mediated Spread of Carbapenem Resistance in : A Three-Year Genome-Based Survey.
Yao Y, Imirzalioglu C, Falgenhauer L, Falgenhauer J, Heinmuller P, Domann E
Antibiotics (Basel). 2024; 13(8).
PMID: 39199982
PMC: 11350871.
DOI: 10.3390/antibiotics13080682.
Healthcare-associated infections and antimicrobial resistance in Canadian acute care hospitals, 2018-2022.
Can Commun Dis Rep. 2024; 50(6):179-196.
PMID: 39132584
PMC: 11315584.
DOI: 10.14745/ccdr.v50i06a02.
Combined Use of Phenotypic Screening and of a Novel Commercial Assay (REALQUALITY Carba-Screen) for the Rapid Molecular Detection of Carbapenemases: A Single-Center Experience.
Novazzi F, Arcari G, Ferrante F, Boutahar S, Genoni A, Carcione D
Diagnostics (Basel). 2024; 14(15).
PMID: 39125475
PMC: 11311838.
DOI: 10.3390/diagnostics14151599.
Performance of Flow Cytometry-Based Rapid Assay in Detection of Carbapenemase-Producing Enterobacterales.
Perez-Viso B, Martins-Oliveira I, Gomes R, Silva-Dias A, Peixe L, Novais A
Int J Mol Sci. 2024; 25(14).
PMID: 39063130
PMC: 11276710.
DOI: 10.3390/ijms25147888.
Linking preterm infant gut microbiota to nasograstric enteral feeding tubes: exploring potential interactions and microbial strain transmission.
Jara J, Alba C, Del Campo R, Fernandez L, Saenz de Pipaon M, Rodriguez J
Front Pediatr. 2024; 12:1397398.
PMID: 38952433
PMC: 11215057.
DOI: 10.3389/fped.2024.1397398.
Distribution and molecular characterization of carbapenemase-producing gram-negative bacteria in Henan, China.
Li C, Chen R, Qiao J, Ge H, Fang L, Liu R
Sci Rep. 2024; 14(1):14418.
PMID: 38909136
PMC: 11193736.
DOI: 10.1038/s41598-024-65106-0.
Carbapenem-Resistant NDM and OXA-48- Producing : From Menacing Superbug to a Mundane Bacteria; A Retrospective Study in a Romanian Tertiary Hospital.
Lazar D, Nica M, Dascalu A, Oprisan C, Albu O, Codreanu D
Antibiotics (Basel). 2024; 13(5).
PMID: 38786163
PMC: 11117283.
DOI: 10.3390/antibiotics13050435.
ARGNet: using deep neural networks for robust identification and classification of antibiotic resistance genes from sequences.
Pei Y, Shum M, Liao Y, Leung V, Gong Y, Smith D
Microbiome. 2024; 12(1):84.
PMID: 38725076
PMC: 11080312.
DOI: 10.1186/s40168-024-01805-0.
Assessing bacterial prevalence and resistance in paediatric meningitis: safeguarding the central nervous system.
Bhatti S, Chaurasia B, Yaqoob E, Ameer J, Shehzad Y, Shahzad K
Ann Med Surg (Lond). 2024; 86(5):2671-2676.
PMID: 38694313
PMC: 11060287.
DOI: 10.1097/MS9.0000000000001953.
Antibiotic Resistance Trends Among Enterobacteriaceae in Saudi Arabia: A Systematic Review.
Arafah A
Cureus. 2024; 16(3):e56614.
PMID: 38646237
PMC: 11031687.
DOI: 10.7759/cureus.56614.
activity of cefepime/taniborbactam and comparator agents against Gram-negative bacterial bloodstream pathogens recovered from patients with cancer.
Gerges B, Rosenblatt J, Truong Y, Jiang Y, Shelburne Sr S, Chaftari A
JAC Antimicrob Resist. 2024; 6(2):dlae060.
PMID: 38601790
PMC: 11005172.
DOI: 10.1093/jacamr/dlae060.
Clinical and genomic characteristics of IMP-producing complex and .
Suzuki D, Sakurai A, Wakuda M, Suzuki M, Doi Y
Antimicrob Agents Chemother. 2024; 68(5):e0167223.
PMID: 38517188
PMC: 11064536.
DOI: 10.1128/aac.01672-23.